eSDM Tool for Depression in Heart Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the eSDM Tool for Depression in Heart Disease treatment?
Is the eSDM Tool for Depression in Heart Disease safe for humans?
How is the eSDM Tool for Depression in Heart Disease different from other treatments?
What is the purpose of this trial?
This trial tests a digital tool that helps heart disease patients with depression work with their doctors to choose the best treatment. The tool also encourages patients to engage in activities that can improve their mood. The goal is to see if this approach reduces depressive symptoms and helps more patients start treatment.
Research Team
Nathalie Moise, MD, MS
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for heart disease patients who also have significant depression symptoms (PHQ9 score ≥10) and speak English or Spanish. It's not for those with psychosis, schizophrenia, bipolar disorder, recent suicide attempts, severe cognitive issues, non-elevated depression symptoms, current pregnancy, or substance abuse problems.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention
Patients receive usual care and are assessed at baseline
Intervention
Patients complete a web application delivering screening, behavioral activation, and shared decision making (eSDM)
Follow-up
Participants are monitored for changes in depressive symptoms and quality of life
Treatment Details
Interventions
- Electronic shared decision making (eSDM) tool
Electronic shared decision making (eSDM) tool is already approved in United States for the following indications:
- Depression in coronary heart disease patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator